ChromaDex Corporation (NASDAQ:CDXC) will hold its 3Q20 earnings conference call with the financial community on 4th November 2020 at 4:30 PM Eastern Time.
The conference call will be webcast live on Internet at www.chromadex.com
Earnings Expectation
ChromaDex Corporation is reporting third quarter financial results on Wednesday 4th November 2020, after market close.
According to analysts surveyed by Thomson Reuters, CDXC is expected to report 3Q20 loss of $ 0.1 per share from revenue of $ 14.29 million.
For the full year, analysts anticipate top line of $ 60.10 million, while looking forward to loss of $ 0.36 per share bottom line.
ChromaDex Corporation operates as a nutraceutical company. The company offers Nicotinamide riboside (NIAGEN), a novel form of vitamin B3 for enhancing nicotinamide adenine dinucleotide (NAD) level used for healthy aging; and Immulina, a spirulina extract and compound, which is used for improving human immune function. It also provides reference standards and fine chemicals to conduct quality control of raw materials and finished products in dietary supplements, cosmetics, food and beverages, and pharmaceutical industries.
